Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > NAD for Sale > Two Receptors, One Shot, Metabolic Transformation Begins
Two Receptors, One Shot, Metabolic Transformation Begins buy - large image1
Two Receptors, One Shot, Metabolic Transformation Begins buy - image1
Two Receptors, One Shot, Metabolic Transformation Begins buy - image2
Two Receptors, One Shot, Metabolic Transformation Begins buy - image3
Two Receptors, One Shot, Metabolic Transformation Begins buy - image4
Two Receptors, One Shot, Metabolic Transformation Begins buy - image5
Two Receptors, One Shot, Metabolic Transformation Begins buy - image6

Two Receptors, One Shot, Metabolic Transformation Begins

128 Inquiries

Unit Price:

$50-60/UNIT FOB

Get Latest Price
CAS No.:

53-84-9

Content:

99.9%

Port:

广州

Packaging:

2.5kg/box

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide raw,Tirzepatide raw,TB500 raw

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    If needed, please add me on WhatsApp at +852 5487 8366 and I’ll send you our product price list.

     This class of synthetic peptides represents a breakthrough by simultaneously activating two key incretin hormones: glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1). While GLP‑1 promotes glucose‑dependent insulin release, slows gastric emptying, and suppresses appetite, GIP complements these actions by enhancing insulin secretion in response to meals and improving fat metabolism. The synergy between the two pathways produces a more robust glycaemic control than either agonist alone.

    Shop Two Receptors, One Shot, Metabolic Transformation Begins-Detailed Image 1

     Clinical trials have shown that such dual agonism not only lowers HbA1c significantly but also drives substantial weight reduction—often exceeding 15–20% of baseline body weight over a year. Beyond glucose and weight, these peptides improve lipid profiles and reduce blood pressure, addressing multiple facets of metabolic syndrome. Their once‑weekly subcutaneous administration, made possible by extended half‑lives, ensures patient convenience and adherence. Adverse effects are mainly gastrointestinal and dose‑dependent, but gradual titration minimises discomfort. This dual‑targeted strategy is reshaping endocrinology, offering a powerful tool for patients with type 2 diabetes and obesity, and ongoing research hints at benefits for heart failure and non‑alcoholic steatohepatitis.

    Shop Two Receptors, One Shot, Metabolic Transformation Begins-Detailed Image 2
    Shop Two Receptors, One Shot, Metabolic Transformation Begins-Detailed Image 3
    ECHEMI Editorial Reference
    NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
    Solid
    NAD zwitterion is a NAD. It has a role as a geroprotector. It derives from a deamido-NAD zwitterion. It is a conjugate base of a NAD(+).|A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)|Nadide is a dinucleotide of adenine and nicotinamide. It has coenzyme activity in redox reactions and also acts as a donor of ADP-ribose moieties.

    Basic Info
    Product Name:

    NAD

    Other Name:

    Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3

    CAS No.:

    53-84-9

    Molecular Formula:

    C21H27N7O14P2

    InChIKeys:

    InChIKey=BAWFJGJZGIEFAR-NNYOXOHSSA-N

    Molecular Weight:

    663.43

    Exact Mass:

    663.109131

    EC Number:

    200-184-4

    NSC Number:

    757121

    DSSTox ID:

    DTXSID2045236

    NCI Thesaurus Code:

    C87339

    HScode:

    29349990

    Characteristics
    PSA:

    321

    XLogP3:

    -1.29620

    Appearance:

    White Powder

    Melting Point:

    140-142 °C (decomp)

    Water Solubility:

    soluble in water at 50mg/ml

    Storage Conditions:

    2-8°C

    Specific rotation:

    D20 -31.5° (c = 1.2 in water)

    Collision Cross Section:

    226.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|227.5 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|222.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|223.8 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|230.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|227 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Hazard Identification

    Classification of the substance or mixture

    Not classified.

    GHS label elements, including precautionary statements

    Pictogram(s) No symbol.
    Signal word

    No signal word

    Hazard statement(s)

    none

    Precautionary statement(s)
    Prevention

    none

    Response

    none

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide raw,Tirzepatide raw,TB500 raw

    Location:

    Room 402, Unit 2, Building 23, Dalutou Village, Jiangdong Sub-district, Yiwu City, Jinhua City, Zhejiang Province (Self-declared)

    Year of Establishment:

    2025

    Established in 2025, Yiwu Weide Trading Company specializes in the research, development, production, and sales of peptide products, synthetic peptide amino acids, beauty and weight-loss products, and raw materials for cosmetics designed to reduce dark spots. The company possesses strong R&D capabilities, sophisticated synthesis technologies, and advanced quality control methods. It actively collaborates with major enterprises and manufacturers, adhering to the philosophy of industrial development to serve society and its customers. The company consistently prioritizes market demand, continuously developing high-tech beauty peptides for spot removal and wrinkle reduction. Its products are primarily exported to the United States, Europe, South Africa, Nigeria, and other countries and regions. With extensive export experience, the company ensures the safe delivery of its shipments.

  • Inquiry History
    128 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Nad+ Injection 500mg/1000mg 99% Purity CAS 53-84-9 USP in 1000mg vials

    1000 G Jan 12, 2024
    United Kingdom

    Top Quality 99% Purity Nicotinamide Adenine Dinucleotide Powder Nad CAS 53-84-9 Nad+

    5 G Oct 25, 2023
    United States

    holesale CAS 53-84-9 99% β-Nicotinamide adenine dinucleotide 99% white powder 99% WP

    1 KG Feb 10, 2025
    India

    ß-Nicotinamide Adenine Dinucleotide hydrate

    1.00 KG Jan 29, 2026
    United Kingdom

    NAD+

    2 KG Mar 4, 2024
    United States

    NAD+ lyophilized powder pure Pharacuetical Grade

    500 G Apr 15, 2026
    India

    Nicotinamide adenine dinucleotide

    300.00 G Jan 10, 2024
    Turkey

    b-Nicotinamide adenine dinucleotide

    1 KG Sep 7, 2023
    India

    Nicotinamide Adenine Dinucleotide Iv Vials

    1.00 KG Sep 12, 2023
    India

    beta-Diphosphopyridine nucleotide

    100 KG Apr 16, 2024
    India

    Nicotinamide Adenine Dinucleotide

    25 KG Apr 7, 2025
    United Kingdom

    NAD+ 500mg for IV therapy

    2 MG Aug 11, 2026
    United States

    NAD+

    1 G Aug 7, 2026
    South Africa

    Nad+

    10 MT Jul 27, 2026
    United States

    β-Nicotinamide adenine dinucleotide

    10 G Jul 16, 2026
    United States

    NAD+

    1000 MG Jul 6, 2026
    United States

    Beta-Nicotinamide adenine dinucleotide Nad+

    1 MG Jun 18, 2026
    United States

    NAD

    500 MG Jun 15, 2026
    United States

    NAD

    1 MT Jun 15, 2026
    India

    NAD

    5 G Jun 10, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.